The chick embryo chorioallantoic membrane (CAM) is a preclinical model widely used for
vascular and anti-vascular effects of therapeutic agents in vivo. In this
study, we examine the suitability of CAM as a predictive model for acute toxicology
studies of drugs by comparing it to conventional mouse and rat models for 10 FDA-approved
anticancer drugs (paclitaxel, carmustine, camptothecin, cyclophosphamide, vincristine,
cisplatin, aloin, mitomycin C, actinomycin-D, melphalan). Suitable formulations for
intravenous administration were determined before the average of median lethal dose
(LD50) and median survival dose (SD50) in the CAM were measured
and calculated for these drugs. The resultant ideal LD50 values were correlated
to those reported in the literature using Pearson’s correlation test for both intravenous
and intraperitoneal routes of injection in rodents. Our results showed moderate
correlations (r2=0.42 − 0.68, P<0.005–0.05) between the
ideal LD50 values obtained using the CAM model with LD50 values from
mice and rats models for both intravenous and intraperitoneal administrations, suggesting
that the chick embryo may be a suitable alternative model for acute drug toxicity
screening before embarking on full toxicological investigations in rodents in development
of anticancer drugs.